This study is designed to look at the affect of SB-705498 on rhinitis symptoms, as induced by
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01439308
Ages eligible for Study
18 Years to 60 Years
Genders eligible for Study
Accepts Healthy Volunteers
Male or female between 18 and 60 years of age inclusive.
Non-child bearing women or women of child bearing potential if they agree to use contraception as indicated by the protocol
Non-smoker for at least 6 months with a pack history <5 pack years (Pack years = (No. of cigarettes smoked/day/20) x No. of years smoked).
Body weight > 50 kg and body mass index (BMI) within the range 19 - 29.9 kg/m2
Capable of giving written informed consent.
Available to complete all the required study measurements.
Normal 12-lead ECG at screening.
Subject must demonstrate reactivity to unilateral, intranasal challenge with the selected single dose of capsaicin, defined as development of TSS ≥ 3.
Normal levels of total plasma IgG and negative allergy skin or Rast test to common aeorallergens.
Good general health, apart from NAR, as determined by a responsible physician.
Past medical history of allergic rhinitis or rhinosinusitis.
Nasal conditions likely to affect the outcome of the study, i.e. nasal septal perforation, nasal polyps, other nasal malformations.
A history of gastrointestinal, hepatic, renal or multiple cardiovascular risk factors.
Positive pre-study drug/alcohol screen.
Positive pre-study Hepatitis B surface antigen or positive Hepatitis C antibody result within 3 months of screening.
A positive test for human immunodeficiency virus (HIV) antibody (if determined by the local standard operating procedures (SOPs)).
History of regular alcohol consumption within 6 months of the study.
Exposure to more than four new chemical entities within 12 months prior to the start of the study.
Participation in a clinical trial with a new molecule entity or any other clinical trial within 4 months of the start of the study.
Use of prescription or non-prescription drugs, as well as of vitamins, herbal and dietary supplements (including St John's Wort) within 2 days prior to each study visit in Part 1 of the study or 14 days prior to the first treatment administration in Part 2 of the study.
Inability to abstain from all intranasal or oral medication to treat nasal symptoms from the first capsaicin challenge to the completion of the study including: sodium cromoglycate, antihistamines, anticholinergics, alpha-adrenergic agonists and corticosteroids
History of drug or other allergy that, in the opinion of the Investigator or GSK Medical Monitor, contraindicates their participation.
Subjects demonstrating hypersensitivity to the placebo capsaicin challenge at baseline screening.
Donation of blood or blood products in excess of 500mL within a 56 day period prior the start of Part 2 of this study.
Pregnant females as determined by positive serum or urine human chorionic gonadotropin
(hCG) test at screening or prior to dosing.
Unwillingness or inability to follow the procedures outlined in the protocol.
History of sensitivity to heparin or heparin-induced thrombocytopenia.
Nicotine levels indicative of smoking or history or regular use of tobacco- or nicotine-containing products within 6 months prior to screening.
For Part 2 only: Subjects with known lactose intolerance.
All locations for NCT01439308
GSK Investigational Site
Amsterdam, Netherlands, 1105 AZ
View full eligibility
Tris trial is registered with FDA with number: NCT01439308. The sponsor of the trial is GlaxoSmithKline and it is looking for 40 volunteers for the current phase.
Official trial title: A Randomized, Double Blind, Placebo Controlled Study to Assessthe Effect of Intranasal Single Dose SB-705498 on the Response Tointranasal Capsaicin Challenge in Non-allergic Rhinitis Patients
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.